Rx Up for Stimulants and Antidepressants, Down for Opioids, 2019 to 2022
MONDAY, Sept. 16, 2024 -- Overall prescription volumes for stimulant and antidepressant medications increased from 2019 to 2022, while prescription volume for opioids decreased, according to a study published online Sept. 13 in JAMA Network Open.
Ashwini Nagappan, from University of California, Los Angeles, and colleagues characterized in-person and telehealth prescribing patterns for stimulants, antidepressants, and opioids from 2019 to 2022. The analysis included quarterly medical and pharmacy claims from the Trilliant Health national all-payer claims database for all 50 states and the District of Columbia.
The researchers found that during the study period, prescriptions filled for stimulants increased by 37.5 percent, with the proportion prescribed from a telehealth visit growing from 1.4 percent in 2019 to 38.1 percent in 2022. While in-person stimulant prescribing rebounded from the pandemic, it remained below the pre-public health emergency average of 97.6 percent. Antidepressant prescriptions increased 20.9 percent during the study, with telehealth’s share growing from 1.5 percent to 31.4 percent. Opioid prescriptions declined before quarter 2 of 2020 and continued to decrease by 17.2 percent overall. Most opioid prescriptions were in-person visits, with telehealth prescriptions reaching 24.1 percent in quarter 2 of 2020 and leveling off at 8.4 percent in 2022, an increase from 0 percent in 2019. Women had a higher rate of telehealth prescribing across all drug types. Rural telehealth prescriptions climbed, but their share of the overall telehealth market decreased over time.
"As telehealth policies continue to evolve post-public health emergency, balancing access to prescriptions with mitigating potential risks, such as misuse, is crucial," the authors write. "Future research should compare telehealth-based and in-person prescribing appropriateness."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Features of Immunesenescence Present in Early Stages of Rheumatoid Arthritis
THURSDAY, Sept. 11, 2025 -- Some features of immunesenescence are present in the very early stages of rheumatoid arthritis (RA), according to a study published online Sept. 3 in...
Urine Biomarker Panel Sensitive, Specific for Prostate Cancer Diagnosis
THURSDAY, Sept. 11, 2025 -- A urine-based biomarker panel has high accuracy for diagnosing prostate cancer (PCa), according to a study published in the September issue of...
Hospitals Vary in Their Definition of Blood Culture Contamination
THURSDAY, Sept. 11, 2025 -- U.S. hospitals vary in how they define blood culture contamination (BCC), according to a study published online July 11 in the Journal of Clinical...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.